CLINICAL OUTCOMES OF MELANOMA BRAIN METASTASES TREATED WITH NIVOLUMAB AND IPILIMUMAB ALONE VERSUS NIVOLUMAB AND IPILIMUMAB WITH STEREOTACTIC RADIOSURGERY

被引：0
|
作者：
Tang, Joseph [1 ]
Mills, Matthew [2 ]
Dohm, Ammoren [2 ]
Khushalani, Nikhil [3 ]
Forsyth, Peter [3 ]
Vogelbaum, Michael A. [4 ]
Wuthrick, Evan [2 ]
Yu, Hsiang-Hsuan Michael [2 ]
Oliver, Daniel [2 ]
Liu, James [5 ]
Ahmed, Kamran [2 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Ann Arbor, MI USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RADT-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery
    Tang, Joseph D.
    Mills, Matthew N.
    Nakashima, Justyn
    Dohm, Ammoren E.
    Khushalani, Nikhil I.
    Forsyth, Peter A.
    Vogelbaum, Michael A.
    Wuthrick, Evan J.
    Yu, Hsiang-Hsuan M.
    Oliver, Daniel E.
    Liu, James K. C.
    Ahmed, Kamran A.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 166 (03) : 431 - 440
  • [2] Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery
    Joseph D. Tang
    Matthew N. Mills
    Justyn Nakashima
    Ammoren E. Dohm
    Nikhil I. Khushalani
    Peter A. Forsyth
    Michael A. Vogelbaum
    Evan J. Wuthrick
    Hsiang-Hsuan M. Yu
    Daniel E. Oliver
    James K. C. Liu
    Kamran A. Ahmed
    Journal of Neuro-Oncology, 2024, 166 : 431 - 440
  • [3] Stereotactic radiosurgery and combined immunotherapy with ipilimumab and nivolumab for melanoma brain metastases
    Bodensohn, R.
    Werner, S.
    Reis, J.
    Escudero, M. Pazos
    Kaempfel, A.
    Hadi, I.
    Forbrig, R.
    Manapov, F.
    Corradini, S.
    Belka, C.
    Theurich, S.
    Heinzerling, L.
    Schlaak, M.
    Niyazi, M.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S983 - S984
  • [4] Safety and Clinical Outcomes of Ipilimumab and Nivolumab Plus Concurrent Stereotactic Radiosurgery for Brain Metastases
    Johnson, C. B.
    Postow, M. A.
    Chapman, P.
    Wolchok, J. D.
    Brennan, C. W.
    Tabar, V. S.
    Chan, T. A.
    Yamada, Y.
    Yang, T. J.
    Beal, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E228 - E228
  • [5] Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases
    Patel, Kirtesh R.
    Shoukat, Sana
    Oliver, Daniel E.
    Chowdhary, Mudit
    Rizzo, Monica
    Lawson, David H.
    Khosa, Faisal
    Liu, Yuan
    Khan, Mohammad K.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 444 - 450
  • [6] Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, C. Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Guidoboni, Massimo
    Maio, Michele
    Schoffski, Patrick
    Carlino, Matteo S.
    Lebbe, Celeste
    McArthur, Grant
    Ascierto, Paolo A.
    Daniels, Gregory A.
    Long, Georgina, V
    Bas, Tuba
    Ritchings, Corey
    Larkin, James
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 127 - +
  • [7] Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
    Minniti, Giuseppe
    Anzellini, Dimitri
    Reverberi, Chiara
    Cappellini, Gian Carlo Antonini
    Marchetti, Luca
    Bianciardi, Federico
    Bozzao, Alessandro
    Osti, Mattia
    Gentile, Pier Carlo
    Esposito, Vincenzo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [8] Nivolumab plus ipilimumab in melanoma brain metastases
    Giacomo, Anna Maria Di
    Maio, Michele
    LANCET ONCOLOGY, 2022, 23 (02): : E53 - E53
  • [9] Treatment of Melanoma Brain Metastases With Nivolumab and Ipilimumab
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (06) : 937 - 937
  • [10] Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
    Mathew, Maya
    Tam, Moses
    Ott, Patrick A.
    Pavlick, Anna C.
    Rush, Stephen C.
    Donahue, Bernadine R.
    Golfinos, John G.
    Parker, Erik C.
    Huang, Paul P.
    Narayana, Ashwatha
    MELANOMA RESEARCH, 2013, 23 (03) : 191 - 195
12345